Transitional CXCL14+ cancer‐associated fibroblasts enhance tumour metastasis and confer resistance to EGFR‐TKIs, revealing therapeutic vulnerability to filgotinib in lung adenocarcinoma. - Xu, Weijiao; Yang, Haitang; Xu, Ke; Zhu, Anshun; Hall, Sean R. R.; Jia, Yunxuan; Zhao, Baicheng; Zhang, Enshuo; Liu, Gang; Xu, Jianlin; Marti, Thomas M.; Peng, Ren‐Wang; et al. (Clinical & Translational Medicine, 2025)